Baillie Gifford's position in Moderna is currently worth $608 Million. That's 0.50% of their equity portfolio (39th largest holding). The investor owns 5.71% of the outstanding Moderna stock. The first Moderna trade was made in Q4 2018. Since then Baillie Gifford bought shares thirteen more times and sold shares on twelve occasions. The investor's estimated purchase price is $3.17 Billion, resulting in a loss of 81%.